Mobility of "HSPG-bound" LPL explains how LPL is able to reach GPIHBP1 on capillaries

Journal of Lipid Research

Volumn 58, Issue 1, 2017, Pages 216-225

  Allan, Christopher M ^a   Larsson, Mikael ^a   Jung, Rachel S ^a   Ploug, Michael ^b,d   Bensadoun, André ^c   Beigneux, Anne P ^a   Fong, Loren G ^a   Young, And Stephen G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Department of Obstetrics Gynecology   (United States)

Author keywords

Chemistry; Endothelial cells; Glycosylphosphatidylinositolanchored high density lipoprotein binding protein; Heparan sulfate proteoglycan; Lipids; Lipolysis and fatty acid metabolism; Lipoprotein lipase; Supplementary chylomicrons; Triglycerides

Indexed keywords

AGAROSE; BINDING PROTEIN; CD31 ANTIGEN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED HIGH DENSITY LIPOPROTEIN BINDING PROTEIN 1; LIPOPROTEIN LIPASE; PROTEOHEPARAN SULFATE; UNCLASSIFIED DRUG; CHYLOMICRON; CULTURE MEDIUM; GPI-HBP1 PROTEIN, MOUSE; LIPOPROTEIN RECEPTOR;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BROWN ADIPOSE TISSUE; CAPILLARY; CARBOHYDRATE TRANSPORT; CELL MOTILITY; CELL SURFACE; CELLULAR DISTRIBUTION; CHO CELL LINE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEP-G2 CELL LINE; IN VIVO STUDY; INTERSTITIAL FLUID; INTERSTITIUM; MAMMARY GLAND; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; WILD TYPE; ANIMAL; CELL LINE; CHEMISTRY; CULTURE MEDIUM; ENZYMOLOGY; GENETICS; HUMAN; LIPOLYSIS; METABOLISM;

ADIPOCYTES; ANIMALS; CAPILLARIES; CELL LINE; CHYLOMICRONS; CULTURE MEDIA; HEP G2 CELLS; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; LIPOLYSIS; LIPOPROTEIN LIPASE; MICE; RECEPTORS, LIPOPROTEIN;

EID: 85009813255     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M072520     Document Type: Article

References (41)

1. Korn, E. D. 1955. Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil. J. Biol. Chem. 215: 15-26.
2. Korn, E. D. 1955. Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J. Biol. Chem. 215: 1-14.
3. Havel, R. J., and R. S. Gordon, Jr. 1960. Idiopathic hyperlipemia: metabolic studies in an affected family. J. Clin. Invest. 39: 1777-1790.
4. Merkel, M., R. H. Eckel, and I. J. Goldberg. 2002. Lipoprotein lipase: genetics, lipid uptake, and regulation. J. Lipid Res. 43: 1997-2006.
5. Ma, Y., H. E. Henderson, M. S. Liu, H. Zhang, I. J. Forsythe, I. Clarke- Lewis, M. R. Hayden, and J. D. Brunzell. 1994. Mutagenesis in four candidate heparin binding regions (residues 279-282, 291-304, 390- 393, and 439-448) and identification of residues affecting heparin binding of human lipoprotein lipase. J. Lipid Res. 35: 2049-2059.
6. Sendak, R. A., K. Melford, A. Kao, and A. Bensadoun. 1998.Identification of the epitope of a monoclonal antibody that inhibits heparin binding of lipoprotein lipase: new evidence for a carboxylterminal heparin-binding domain. J. Lipid Res. 39: 633-646.
7. Lookene, A., M. S. Nielsen, J. Gliemann, and G. Olivecrona. 2000. Contribution of the carboxy-terminal domain of lipoprotein lipase to interaction with heparin and lipoproteins. Biochem. Biophys. Res. Commun. 271: 15-21.
8. Hata, A., D. N. Ridinger, S. Sutherland, M. Emi, Z. Shuhua, R. L. Myers, K. Ren, T. Cheng, I. Inoue, D. E. Wilson, et al. 1993. Binding of lipoprotein lipase to heparin. Identification of five critical residues in two distinct segments of the amino-terminal domain. J. Biol. Chem. 268: 8447-8457.
9. de Man, F. H., F. de Beer, A. van der Laarse, A. H. Smelt, and L. M. Havekes. 1997. Lipolysis of very low density lipoproteins by heparan sulfate proteoglycan-bound lipoprotein lipase. J. Lipid Res. 38: 2465-2472.
10. Davies, B. S. J., A. P. Beigneux, R. H. Barnes II, Y. Tu, P. Gin, M. M. Weinstein, C. Nobumori, R. Nyrén, I. J. Goldberg, G. Olivecrona, et al. 2010. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab. 12: 42-52.
11. Beigneux, A. P., B. S. Davies, P. Gin, M. M. Weinstein, E. Farber, X. Qiao, F. Peale, S. Bunting, R. L. Walzem, J. S. Wong, et al. 2007. Glycosylphosphatidylinositol-anchored high-density lipoproteinbinding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab. 5: 279-291.
12. Goulbourne, C. N., P. Gin, A. Tatar, C. Nobumori, A. Hoenger, H. Jiang, C. R. Grovenor, O. Adeyo, J. D. Esko, I. J. Goldberg, et al. 2014. The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries. Cell Metab. 19: 849-860.
13. Franssen, R., S. G. Young, F. Peelman, J. Hertecant, J. A. Sierts, A. W. Schimmel, A. Bensadoun, J. J. Kastelein, L. G. Fong, G. M. Dallinga- Thie, et al. 2010. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects. Circ Cardiovasc Genet. 3: 169-178.
14. Olivecrona, G., E. Ehrenborg, H. Semb, E. Makoveichuk, A. Lindberg, M. R. Hayden, P. Gin, B. S. Davies, M. M. Weinstein, L. G. Fong, et al. 2010. Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia. J. Lipid Res. 51: 1535-1545.
15. Charrière, S., N. Peretti, S. Bernard, M. Di Filippo, A. Sassolas, M. Merlin, M. Delay, C. Debard, E. Lefai, A. Lachaux, et al. 2011. GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia. J. Clin. Endocrinol. Metab. 96: E1675-E1679.
16. Yamamoto, H., M. Onishi, N. Miyamoto, R. Oki, H. Ueda, M. Ishigami, H. Hiraoka, Y. Matsuzawa, and S. Kihara. 2013. Novel combined GPIHBP1 mutations in a patient with hypertriglyceridemia associated with CAD. J. Atheroscler. Thromb. 20: 777-784.
17. Rios, J. J., S. Shastry, J. Jasso, N. Hauser, A. Garg, A. Bensadoun, J. C. Cohen, and H. H. Hobbs. 2012. Deletion of GPIHBP1 causing severe chylomicronemia. J. Inherit. Metab. Dis. 35: 531-540.
18. Coca-Prieto, I., O. Kroupa, P. Gonzalez-Santos, J. Magne, G. Olivecrona, E. Ehrenborg, and P. Valdivielso. 2011. Childhoodonset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation. J. Intern. Med. 270: 224-228.
19. Plengpanich, W., S. G. Young, W. Khovidhunkit, A. Bensadoun, H. Karnman, M. Ploug, H. Gardsvoll, C. S. Leung, O. Adeyo, M. Larsson, et al. 2014. Multimerization of glycosylphosphatidylinositolanchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain. J. Biol. Chem. 289: 19491-19499.
20. Beigneux, A. P., R. Franssen, A. Bensadoun, P. Gin, K. Melford, J. Peter, R. L. Walzem, M. M. Weinstein, B. S. Davies, J. A. Kuivenhoven, et al. 2009. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler. Thromb. Vasc. Biol. 29: 956-962.
21. Gonzaga-Jauregui, C., S. Mir, S. Penney, S. Jhangiani, C. Midgen, M. Finegold, D. M. Muzny, M. Wang, C. A. Bacino, R. A. Gibbs, et al. 2014. Whole-exome sequencing reveals GPIHBP1 mutations in infantile colitis with severe hypertriglyceridemia. J. Pediatr. Gastroenterol. Nutr. 59: 17-21.
22. Ariza, M. J., P. L. Martinez-Hernandez, D. Ibarretxe, C. Rabacchi, J. Rioja, C. Grande-Aragon, N. Plana, P. Tarugi, G. Olivecrona, S. Calandra, et al. 2016. Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis. J. Clin. Lipidol. 10: 92-100.e1.
23. Fong, L. G., S. G. Young, A. P. Beigneux, A. Bensadoun, M. Oberer, H. Jiang, and M. Ploug. 2016. GPIHBP1 and plasma triglyceride metabolism. Trends Endocrinol. Metab. 27: 455-469.
24. Mysling, S., K. K. Kristensen, M. Larsson, A. P. Beigneux, H. Gardsvoll, L. G. Fong, A. Bensadouen, T. J. Jorgensen, S. G. Young, and M. Ploug. 2016. The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain. eLife. 5: e12095.
25. Weinstein, M. M., L. Yin, A. P. Beigneux, B. S. Davies, P. Gin, K. Estrada, K. Melford, J. R. Bishop, J. D. Esko, G. M. Dallinga-Thie, et al. 2008. Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice. J. Biol. Chem. 283: 34511-34518.
26. Page, S., A. Judson, K. Melford, and A. Bensadoun. 2006. Interaction of lipoprotein lipase and receptor-associated protein. J. Biol. Chem. 281: 13931-13938.
27. Beigneux, A. P., L. G. Fong, A. Bensadoun, B. S. Davies, M. Oberer, H. Gardsvoll, M. Ploug, and S. G. Young. 2015. GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding. Circ. Res. 116: 624-632.
28. Gin, P., A. P. Beigneux, C. Voss, B. S. Davies, J. A. Beckstead, R. O. Ryan, A. Bensadoun, L. G. Fong, and S. G. Young. 2011. Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells. Arterioscler. Thromb. Vasc. Biol. 31: 176-182.
29. Gårdsvoll, H., L. V. Hansen, T. J. Jørgensen, and M. Ploug. 2007. A new tagging system for production of recombinant proteins in Drosophila S2 cells using the third domain of the urokinase receptor. Protein Expr. Purif. 52: 384-394.
30. Ben-Zeev, O., H. Z. Mao, and M. H. Doolittle. 2002. Maturation of lipoprotein lipase in the endoplasmic reticulum. Concurrent formation of functional dimers and inactive aggregates. J. Biol. Chem. 277: 10727-10738.
31. Zaiss, A. K., R. Lawrence, D. Elashoff, J. D. Esko, and H. R. Herschman. 2011. Differential effects of murine and human factor X on adenovirus transduction via cell-surface heparan sulfate. J. Biol. Chem. 286: 24535-24543.
32. Bengtsson-Olivecrona, G., and T. Olivecrona. 1992. Assay of lipoprotein lipase and hepatic lipase. In Lipoprotein Analysis: A Practical Approach. R. E. Skinner and C. A. Converse, editors. Oxford University Press, Oxford, UK. 169-185.
33. Beigneux, A. P., P. Gin, B. S. J. Davies, M. M. Weinstein, A. Bensadoun, L. G. Fong, and S. G. Young. 2009. Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase. J. Biol. Chem. 284: 30240-30247.
34. Wang, Y., J. Tong, S. Li, R. Zhang, L. Chen, Y. Wang, M. Zheng, M. Wang, G. Liu, Y. Dai, et al. 2011. Over-expression of human lipoprotein lipase in mouse mammary glands leads to reduction of milk triglyceride and delayed growth of suckling pups. PLoS One. 6: e20895.
35. Nugent, M. A., and E. R. Edelman. 1992. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. Biochemistry. 31: 8876-8883.
36. Lookene, A., O. Chevreuil, P. Ostergaard, and G. Olivecrona.1996. Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: stoichiometry, stabilization, and kinetics. Biochemistry. 35: 12155-12163.
37. Reimund, M., M. Larsson, O. Kovrov, S. Kasvandik, G. Olivecrona, and A. Lookene. 2015. Evidence for two distinct binding sites for lipoprotein lipase on glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1). J. Biol. Chem. 290: 13919-13934.
38. Gin, P., L. Yin, B. S. Davies, M. M. Weinstein, R. O. Ryan, A. Bensadoun, L. G. Fong, S. G. Young, and A. P. Beigneux. 2008. The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons. J. Biol. Chem. 283: 29554-29562.
39. Catoire, M., S. Alex, N. Paraskevopulos, F. Mattijssen, I. Evers-van Gogh, G. Schaart, J. Jeppesen, A. Kneppers, M. Mensink, P. J. Voshol, et al. 2014. Fatty acid-inducible ANGPTL4 governs lipid metabolic response to exercise. Proc. Natl. Acad. Sci. USA. 111: E1043-E1052.
40. Dijk, W., A. P. Beigneux, M. Larsson, A. Bensadoun, S. G. Young, and S. Kersten. 2016. Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes. J. Lipid Res. 57: 1670-1683.
41. Hintersteiner, M., and M. Auer. 2013. A two-channel detection method for autofluorescence correction and efficient on-bead screening of one-bead one-compound combinatorial libraries using the COPAS fluorescence activated bead sorting system. Methods Appl. Fluoresc. 1: 017001.